CBX3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.415600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.897200E-01
Normal-vs-Stage2
7.510400E-01
Normal-vs-Stage3
3.647800E-01
Normal-vs-Stage4
9.327800E-01
Stage1-vs-Stage2
2.807600E-01
Stage1-vs-Stage3
9.420000E-01
Stage1-vs-Stage4
3.597800E-01
Stage2-vs-Stage3
3.287200E-01
Stage2-vs-Stage4
6.122800E-01
Stage3-vs-Stage4
4.375800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.316400E-01
Normal-vs-AfricanAmerican
5.801400E-01
Normal-vs-Asian
7.249000E-01
Caucasian-vs-AfricanAmerican
9.878400E-01
Caucasian-vs-Asian
9.996200E-01
AfricanAmerican-vs-Asian
9.913200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.374600E-01
Normal-vs-Female
6.641000E-01
Male-vs-Female
8.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.929800E-01
Normal-vs-Age(41-60Yrs)
9.605000E-01
Normal-vs-Age(61-80Yrs)
4.999400E-01
Normal-vs-Age(81-100Yrs)
8.401000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.369430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.733000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.708200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.803600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.582400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.141200E-01
Normal-vs-Daily Drinker
6.141200E-01
Normal-vs-Weekly Drinker
4.864400E-01
Normal-vs-Occasional Drinker
9.769000E-01
Normal-vs-Social Drinker
6.896600E-01
Non Drinker-vs-Daily Drinker
9.002200E-01
Non Drinker-vs-Weekly Drinker
8.285800E-01
Non Drinker-vs-Occasional Drinker
2.934400E-01
Non Drinker-vs-Social Drinker
6.252200E-01
Daily Drinker-vs-Weekly Drinker
7.758600E-01
Daily Drinker-vs-Occasional Drinker
4.152000E-01
Daily Drinker-vs-Social Drinker
7.507000E-01
Weekly Drinker-vs-Occasional Drinker
3.299000E-01
Weekly Drinker-vs-Social Drinker
5.547800E-01
Occasional Drinker-vs-Social Drinker
6.169200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.740200E-01
Normal-vs-Grade 2
7.946600E-01
Normal-vs-Grade 3
7.181800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.581900E-03
Grade 1-vs-Grade 3
6.989700E-04
Grade 1-vs-Grade 4
9.740200E-01
Grade 2-vs-Grade 3
1.010600E-01
Grade 2-vs-Grade 4
7.946600E-01
Grade 3-vs-Grade 4
7.181800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.267200E-01
Normal-vs-NonDiabetic
6.688000E-01
Diabetic-vs-NonDiabetic
2.066600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.853200E-01
Normal-vs-NoPancreatitis
6.131200E-01
Pancreatitis-vs-NoPancreatitis
6.475600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.272200E-01
Normal-vs-N1
7.701400E-01
N0-vs-N1
2.137800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.148400E-01
Normal-vs-TP53-NonMutant
3.637400E-01
TP53-Mutant-vs-TP53-NonMutant
1.56389999839135E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
